TABLE 2

Biodistribution of 18F-FE-SA5845 in Tumor-Bearing Rats 60 Minutes After Injection

TissueControl (n = 5)Haloperidol (n = 5)P
Cerebellum1.41 ± 0.230.43 ± 0.12<0.0001
Cerebral cortex1.26 ± 0.310.45 ± 0.160.0005
Rest brain1.42 ± 0.280.41 ± 0.130.0001
Adipose tissue0.46 ± 0.180.45 ± 0.26NS
Bladder1.61 ± 0.940.95 ± 0.45NS
Bone0.42 ± 0.140.39 ± 0.13NS
Heart0.47 ± 0.160.66 ± 0.25NS
Large intestine1.76 ± 0.180.84 ± 0.300.0002
Small intestine2.35 ± 0.441.13 ± 0.350.0006
Kidney4.95 ± 0.841.77 ± 0.58<0.0001
Liver9.28 ± 1.505.58 ± 2.24<0.01
Lung2.93 ± 0.832.50 ± 1.09NS
Muscle0.20 ± 0.070.25 ± 0.10NS
Pancreas4.23 ± 0.854.39 ± 2.69NS
Plasma0.12 ± 0.030.23 ± 0.05<0.001
Red blood cells0.08 ± 0.010.16 ± 0.05<0.05
Spleen2.05 ± 0.461.43 ± 0.530.08
Submandibular2.33 ± 0.851.31 ± 0.730.06
C6 tumor*0.92 ± 0.390.37 ± 0.180.0005
Urine9.71 ± 6.549.45 ± 3.88NS
Tumor/plasma*8.0 ± 3.21.4 ± 0.9<0.0001
Tumor/muscle*4.9 ± 2.81.5 ± 0.90.001
  • * Twice as much data (2 n) since each rat had 2 tumors.

  • NS = not significant.

    SUVs (and dimensionless ratios) are listed (mean ± SD).